Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Puglisi

Premium

PTC Therapeutics said this week that it has named Joseph Puglisi to its scientific advisory board.

Puglisi is currently an associate professor of structural biology and director of the Stanford Magnetic Resonance Laboratory at Stanford University School of Medicine, said PTC. His work focuses on the “dynamics of ribosome during translation, the molecular basis for antibiotic action against the ribosome, the mechanism of eukaryotic translation initiation and elongation, the structure and function of the hepatitis C virus internal ribosome, and RNA-protein interactions in the HIV virus,” the company added.

Puglisi received a PhD in biophysical chemistry from the University of California, Berkeley, according to PTC.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.